Clinical trial
Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial…
NCT00327717 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00327717 |
|---|---|
| Title | Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures |
| Official title | A Multicenter, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Partial Seizures |
| Intervention type | Drug |
| Interventions | Zonisamide, Placebo |
| Enrollment | 240 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 18, 2006 |
| Last update posted | Aug 15, 2014 |
| Countries | China |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: